Gregory Alan Korbel - 25 Feb 2022 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
SVP, Chief Business Officer
Signature
/s/ Scott M. Coiante, attorney-in-fact
Issuer symbol
APRE
Transactions as of
25 Feb 2022
Net transactions value
-$2,307
Form type
4
Filing time
01 Mar 2022, 16:02:14 UTC
Previous filing
03 Dec 2021
Next filing
14 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability $2,307 -1,326 -7.7% $1.74 15,841 25 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 3,333 restricted stock units.